Results 211 to 220 of about 1,100,188 (302)

Efficacy and safety of glucocorticoids for acute drug-induced liver injury with hyperbilirubinemia: protocol of a multicenter randomized controlled trial. [PDF]

Ther Adv Gastroenterol
Li Q, Lin Y, Zeng X, Zhou L, Wang F, Ye Q, Gao Y, Guo L, Zhu J, Li J, Li Y, Shao L, Hu Y, Xiao J, Jia A, Wang D, Chang L, Wang J, Zhang J, Wang R, Gao F, Wu Q, Hu P, Zhu C, Cai L, Ran Y, Li Y, Zhang J, Ran Y, Wang C, Wang N, Zhang J, Zhang X, Li J, Sun J, Chu Y, Ma Y, Wang T, Zheng Z, Shen Y, Qi X, Xie W.   +41 more
europepmc   +1 more source

From Lab to Landscape: Environmental Biohybrid Robotics for Ecological Futures

Advanced Robotics Research, EarlyView.
This Perspective explores environmental biohybrid robotics, integrating living tissues, microorganisms, and insects for operation in real‐world ecosystems. It traces the leap from laboratory experiments to forests, wetlands, and urban environments and discusses key challenges, development pathways, and opportunities for ecological monitoring and ...
Miriam Filippi
wiley   +1 more source

Efficacy and safety of subthreshold micropulse laser for chronic central serous chorioretinopathy: a systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Luo W, He Y.
europepmc   +1 more source

PD‐1 Inhibits CD4+ TRM‐Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC

Advanced Science, EarlyView.
CD4+ tissue‐resident memory T cells (TRMs) in non‐small cell lung cancer recruit conventional type 1 dendritic cells via XCL1‐XCR1 signaling, orchestrating antitumor immunity. The costimulatory molecule JAML is essential for this process. PD‐1 blockade restores JAML expression and cDC1 mobilization, while JAML agonists synergize with anti‐PD‐1 therapy,
Zheyu Shao, Qinyuan Liu, Zhongwei Xin, Zhiyao Zhou, Mingjie Lin, Di Chen, Zhixing Hao, Yongyuan Chen, Wenxuan Wu, Shuyang Zhang, Xiaoke Chen, Xia Xu, Jinfan Li, Wei Lin, Yuhao Lu, Dang Wu, Pin Wu   +16 more
wiley   +1 more source

Transformer maintenance strategy based on improved risk assessment method considering operation and maintenance costs. [PDF]

PLoS One
Guo H, Wang Y, Bo H, Zhang J, Yang Y, Guo Z.   +5 more
europepmc   +1 more source

Anti‐PD‐1 Nanobody‐Armored MSLN CAR‐T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies

Advanced Science, EarlyView.
A novel therapy using engineered immune cells (NAC‐T cells) showed promise for refractory malignant mesothelioma. Based on the encouraging preclinical data, the first‐in‐human trial is initiated, demonstrating tolerable safety and promising anti‐tumor activity (ORR 63.6%, DCR 100%, including one CR).
Yan Sun, Haochen Yang, Qing Xu, Xingya Li, Jinxing Lou, Jianchun Duan, Jiachen Xu, Zhuqing Liu, Yong Xia, Zhicai Lin, Linlin Li, Dan Sun, Jiaguo Li, Tao Liu, Jun Guo, Wenfeng Xu, Weimin Zhu, Yi Liu, Boyang Sun, Jia Zhong, Lijie Rong, Qijun Qian, Chenqi Xu, Jie Wang   +23 more
wiley   +1 more source

Factors associated with fatigue in patients with systemic lupus erythematosus in an outpatient tertiary care setting: a cross-sectional cohort study. [PDF]

BMJ Open
Chapman M, Rizvi AM, Qutab M, Munday A, Biehl A, Manna Z, Hasni S.   +6 more
europepmc   +1 more source

Union-Endicott Central School District and Union-Endicott Transportation Employees Association (2007) [PDF]

, 2007

core   +1 more source

A Biomarker‐Driven Ovary–Endometrium Organ‐on‐a‐Chip Mimicking 3D Multicellular Complexity and Menstrual Cyclicity for Predicting Reproductive Toxicity

Advanced Science, EarlyView.
We present a dual‐organ, biomarker‐integrated ovaryendometrium organ‐on‐a‐chip that recapitulates 3D tissue complexity, menstrual cycle dynamics, and hormonal crosstalk. This platform enables real‐time, cell‐typespecific fluorescent readouts of reproductive toxicity using ANGPTL4 and SERPINB2 as early‐response reporters.
Soo‐Rim Kim, Eun‐kyung Min, Choon‐Mi Lee, Chan Hum Park, Byung‐Chul Oh, YunJae Jung, In‐Sun Hong   +6 more
wiley   +1 more source

Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review. [PDF]

RMD Open
Calvo-Río V, Secada-Gómez C, Martín-Gutiérrez A, Retuerto-Guerrero M, Font J, Casafont-Solé I, Mayo-Juanatey A, Alegre Sancho JJ, Freites D, Hormigos C, Garrido Puñal N, González Arribas G, Miguélez Sanchez JR, García-Valle A, Ibañez M, Lozano Morillo F, García Manzanares Á, Sandoval-Moreno S, Cortes-Hernandez J, Palma Sanchez D, Lojo L, Cervantes Pérez EC, Collado P, Arciniega Larios C, Sala Icardo L, Labrador-Sánchez E, Peralta-Ginés C, Urionagüena Onaindia I, Plaza-Aulestia N, Medina Malone M, Gómez de Salazar JR, Corteguera M, Cebrián-Méndez L, Antón Pages FA, Lamua Riazuelo JR, Fábregas Canales MD, Alados Hernández MJ, Garijo Bufort M, Pàmies A, Sarabia de Ardanaz L, Aguirre-Del-Pino R, Cabezas Lefler JÁ, Seijas-Lopez Á, Carrasco Cubero MDC, López-Cerón Cofiño A, Ortiz-Santamaria V, Laiño Piñeiro M, Ordás Calvo C, Arconada Lopez C, Urruticoechea-Arana A, Garcia Magallon B, Acosta Alfaro AV, Leal Rodriguez S, Salido Olivares M, Lavilla Villar P, Brandy-García AM, Ros Vilamajo I, García Martos Á, Magallares Lopez BP, Sada Urmeneta G, Córdoba Martín C, Riera E, Bejerano C, Castañeda S, Blanco R.   +64 more
europepmc   +1 more source